MARKET

ANPCY

CELLBXHEALTH PLC
ANPCY
OTCQX
Delisted
P/E
P/S
P/B
MARKET CAP
-0.1107
0.602
0.135
-
CELLBXHEALTH PLC FY REVENUE GBP 1.6 MILLION
Reuters · 01/16 07:00
CORRECTED-CELLBXHEALTH PLC FY REVENUE GBP 1.4 MILLION (CORRECTS AMOUNT)
Reuters · 01/16 07:00
CelLBxHealth Showcases CTC Diagnostic Advances at World ADC Conference
Reuters · 11/05/2025 07:00
BRIEF-Angle Appoints Peter Collins As Interim Chief Executive Officer
Reuters · 10/16/2025 06:37
ANGLE plc Appoints Peter Collins as Interim CEO and Klaas de Boer as Senior Board Advisor
Reuters · 10/16/2025 06:00
ANGLE plc to change name to CelLBxHealth plc
Reuters · 10/08/2025 06:00
ANGLE plc Announces Breakthrough Clinical Study Demonstrating Parsortix System's Ability to Detect Circulating Tumor Cells in Glioblastoma Patients
Reuters · 09/29/2025 06:00
Weekly Report: what happened at ANPCY last week (0908-0912)?
Weekly Report · 09/15/2025 11:48
More

Webull offers CELLBXHEALTH PLC stock information, including OTCQX: ANPCY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANPCY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANPCY stock methods without spending real money on the virtual paper trading platform.